Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 44
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
AAPS PharmSciTech ; 19(3): 1160-1167, 2018 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-29238945

RESUMEN

To develop a single-shot vaccine containing diphtheria toxoid (DT) with a sufficient immune response, poly(lactide-co-glycolide) (PLGA) microspheres were prepared by water-in-oil-in-water double emulsification and solvent extraction techniques using low or high-molecular-weight PLGA (LMW-MS or HMW-MS). Stearic acid (SA) was introduced to HMW-MS (HMW/SA-MS) as a release modulator. Mean particle sizes (dvs, µm) varied between the prepared microspheres, with LMW-MS, HMW-MS, and HMW/SA-MS having the sizes of 29.83, 110.59, and 69.5 µm, respectively; however, the protein entrapment and loading efficiency did not vary, with values of 15.2-16.8 µg/mg and 61-75%, respectively. LMW-MS showed slower initial release (~ 2 weeks) but faster and higher release of antigen during weeks 3~7 than did HMW-MS. HMW/SA-MS showed rapid initial release followed by a continuous release over an extended period of time (~ 12 weeks). Mixed PLGA microspheres (MIX-MS), a combination of HMW/SA-MS and LMW-MS (1:1), demonstrated a sufficient initial antigen release and a subsequent boost release in a pulsatile manner. Serum antibody levels were measured by ELISA after DT immunization of Balb/c mice, and showed a greater response to MIX-MS than to alum-adsorbed DT (control). A lethal toxin challenge test with MIX-MS (a DT dose of 18 Lf) using Balb/c mice revealed complete protection, indicating a good candidate delivery system for a single-shot immunization.


Asunto(s)
Toxoide Diftérico/administración & dosificación , Poliglactina 910/química , Animales , Toxoide Diftérico/inmunología , Femenino , Ratones , Ratones Endogámicos BALB C , Microesferas , Tamaño de la Partícula , Vacunación
2.
Biol Pharm Bull ; 40(5): 630-637, 2017.
Artículo en Inglés | MEDLINE | ID: mdl-28458348

RESUMEN

The aim of the present study was to examine the inhibitory roles and mechanisms of hirsutenone (HTN) in the regulation of osteoclastogenesis. Gene levels were compared to assure the effects of HTN on osteoclastogenesis in mouse splenocytes/CD4+ T cells, mouse macrophage-like cell line RAW264.7 (preosteoclast), MG63 (osteoblast), and RPMI1788 (B cell) cells. The mechanism by which HTN regulates the degradation of tumor necrosis factor receptor-associated factor 6 (TRAF6) and inhibits inhibitor of kappaB (IκB) and nuclear factor-kappaB (NF-κB) signaling was examined by Western blotting and luciferase reporter assays. Our results demonstrated that HTN effectively downregulated the expression of interferon γ (IFNγ), interleukin-22 (IL-22), IL-1ß, and tartrate-resistant acid phosphatase (TRAP) in splenocyte-/CD4+-RAW264.7 co-culture system. Moreover, receptor activator of nuclear factor-κB ligand (RANKL) and CD25 expression were also significantly inhibited in MG63 and CD4+ single culture system, suggesting an additional independent effect of HTN on osteoclastogenesis. Notably, TRAF6 was markedly degraded along with a decrease in nuclear factor of activated T-cells (NFATc) and NF-κB activities in RAW264.7 cells. Finally, we concluded that HTN directly or indirectly inhibits osteoclastogenesis via the inhibition of NF-κB signaling by promoting TRAF6 degradation, and plays a crucial role in suppressing the expression of RANKL and cytokines expressed in IFNγ-producing T-helper 1 (Th1) cells. These findings suggest that HTN may be a promising therapeutic candidate for diseases resulting from bone loss.


Asunto(s)
Catecoles/farmacología , Diarilheptanoides/farmacología , Interferón gamma/antagonistas & inhibidores , FN-kappa B/antagonistas & inhibidores , Osteoclastos/efectos de los fármacos , Células TH1/efectos de los fármacos , Alnus/química , Animales , Linfocitos T CD4-Positivos/metabolismo , Supervivencia Celular/efectos de los fármacos , Citocinas/antagonistas & inhibidores , Citocinas/farmacología , Ratones , Ratones Endogámicos BALB C , Osteogénesis/efectos de los fármacos , Corteza de la Planta/química , Ligando RANK/genética , Células RAW 264.7 , Transducción de Señal/efectos de los fármacos , Bazo/química , Bazo/citología , Células Madre/efectos de los fármacos , Fosfatasa Ácida Tartratorresistente/biosíntesis , Fosfatasa Ácida Tartratorresistente/genética
3.
Gen Physiol Biophys ; 35(4): 487-495, 2016 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-27527723

RESUMEN

The potential risks that electromagnetic fields (EMF) pose to human physiology have been debated for several decades, especially considering that EMF is almost omnipresent and some occupations involve regular exposure to particularly strong fields. In the present study, the effects of 60 Hz 0.3 mT EMF on CD4+ T cells were evaluated. Production of T cell related cytokines, IFN-γ and IL-2, was not altered in CD4+ T cells that were exposed to EMF, and cell proliferation was also unaffected. The expression of genes present in a subset of Th17 cells was upregulated following EMF exposure, and the production of effector cytokines of the IL-17A subset also increased. To determine signaling pathways that underlie these effects, phosphorylation of STAT3 and SMAD3, downstream molecules of cytokines critical for Th17 induction, was analyzed. Increased SMAD3 phosphorylation level in cells exposed to EMF, suggesting that SMAD3 may be at least in part causing the increased Th17 cell production. Differentiation of Treg, another CD4+ T cell subset induced by SMAD3 signaling, was also elevated following EMF exposure. These results suggest that 60 Hz 0.3 mT EMF exposure amplifies TGF-ß signaling and increases the generation of specific T cell subsets.


Asunto(s)
Diferenciación Celular/fisiología , Campos Electromagnéticos , Linfocitos T Reguladores/citología , Linfocitos T Reguladores/fisiología , Células Th17/citología , Células Th17/fisiología , Animales , Diferenciación Celular/efectos de la radiación , Células Cultivadas , Citocinas/metabolismo , Relación Dosis-Respuesta en la Radiación , Masculino , Ratones , Ratones Endogámicos C57BL , Dosis de Radiación , Exposición a la Radiación , Linfocitos T Reguladores/efectos de la radiación , Células Th17/efectos de la radiación
4.
Arch Pharm Res ; 39(5): 705-12, 2016 May.
Artículo en Inglés | MEDLINE | ID: mdl-27071615

RESUMEN

T cells play an important role in adaptive immune responses that destroy pathogens or infected cells. Therefore, regulation of T cell activity is important in various diseases, such as autoimmune diseases, hypersensitivity, and cancer. The conjugation of small ubiquitin-related modifier (SUMO) is a post-translational protein modification that regulates activity, stability, and subcellular translocation of target proteins. In this study, CD8(+) T cells overexpressing SUMO2 showed greater proliferation and cytotoxic activity against tumor cells in the presence of IL-6 than wild-type CD8(+) T cells in vitro. These CD8(+) T cell functions were suppressed during treatment with MEK1 or PI3K-specific inhibitors. Therefore, our findings suggest that IL-6-derived signaling pathways, including the MEK1 and PI3K pathways, are upregulated by SUMO2 overexpression. However, transgenic expression of SUMO2 in T cells did not modulate Th1/2 balance. Collectively, our results showed that SUMO2-Tg promotes cytotoxic activity against tumor cells by increasing the proliferation and cytotoxicity of CD8(+) T cells.


Asunto(s)
Linfocitos T CD8-positivos/inmunología , Proliferación Celular , Interleucina-6/inmunología , Proteínas Modificadoras Pequeñas Relacionadas con Ubiquitina/genética , Inmunidad Adaptativa , Animales , Linfocitos T CD8-positivos/citología , Linfocitos T CD8-positivos/metabolismo , Técnicas de Cultivo de Célula , Línea Celular Tumoral , Supervivencia Celular/inmunología , Diabetes Mellitus Experimental/sangre , Diabetes Mellitus Experimental/inmunología , Diabetes Mellitus Tipo 1/sangre , Diabetes Mellitus Tipo 1/inmunología , Inmunoglobulina E/sangre , Interleucina-6/farmacología , Activación de Linfocitos/inmunología , MAP Quinasa Quinasa 1/metabolismo , Masculino , Ratones Endogámicos C57BL , Ratones Transgénicos , Fosfatidilinositol 3-Quinasas/metabolismo , Proteínas Modificadoras Pequeñas Relacionadas con Ubiquitina/inmunología , Linfocitos T Citotóxicos/citología , Linfocitos T Citotóxicos/inmunología , Linfocitos T Citotóxicos/metabolismo
5.
Artículo en Inglés | MEDLINE | ID: mdl-27110266

RESUMEN

It is well recognized that regulating the hair follicle cycle in association with Wnt signaling is one of the most interesting targets for promoting hair regrowth. In this study, we examined whether selected herbal medicines processed by decoction and fermentation promote hair growth by upregulating the number and size of hair follicles and Wnt signaling, including activation of ß-catenin and Akt in telogen-synchronized C57BL/6N mice. The results revealed that the fermented extract after decoction (FDE) more effectively promoted hair growth than that of a nonfermented extract (DE). Notably, FDE effectively enhanced formation of hair follicles with clearer differentiation between the inner and outer root sheath, which is observed during the anagen phase. Mechanistic evidence was found for increased ß-catenin and Akt phosphorylation levels in dorsal skin tissue along with elevated expression of hair regrowth-related genes, such as Wnt3/10a/10b, Lef1, and fibroblast growth factor 7. In conclusion, our findings suggest that FDE plays an important role in regulating the hair cycle by increasing expression of hair regrowth-related genes and activating downstream Wnt signaling targets.

6.
Int Immunopharmacol ; 32: 125-132, 2016 03.
Artículo en Inglés | MEDLINE | ID: mdl-26828762

RESUMEN

Macrophages are archetypal innate immune cells that play crucial roles in the recognition and phagocytosis of invading pathogens, which they identify using pattern recognition receptors (PRRs). Dectin-1 is essential for antifungal immune responses, recognizing the fungal cellular component ß-glucan, and its role as a PRR has been of increasing interest. Previously, we discovered and characterized a novel biaryl amide compound, MPS 03, capable of inhibiting macrophage phagocytosis of zymosan. Therefore, in this study we aimed to identify other biaryl amide compounds with greater effectiveness than MPS 03, and elucidate their cellular mechanisms. Several MPS 03 derivatives were screened, four of which reduced zymosan phagocytosis in a similar manner to MPS 03. To establish whether such phagocytosis inhibition influenced the production of inflammatory mediators, pro-inflammatory cytokine and nitric oxide (NO) levels were measured. The production of TNF-α, IL-6, IL-12, and NO was significantly reduced in a dose-dependent manner. Moreover, the inflammation-associated MAPK signaling pathway was also affected by biaryl amide compounds. To investigate the underlying cellular mechanism, PRR expression was measured. MPS 03 and its derivatives were found to inhibit zymosan phagocytosis by decreasing Dectin-1 expression. Furthermore, when macrophages were stimulated by zymosan after pretreatment with biaryl amide compounds, downstream transcription factors such as NFAT, AP-1, and NF-κB were downregulated. In conclusion, biaryl amide compounds reduce zymosan-induced inflammatory responses by downregulating Dectin-1 expression. Therefore, such compounds could be used to inhibit Dectin-1 in immunological experiments and possibly regulate excessive inflammatory responses.


Asunto(s)
Amidas/farmacología , Antiinflamatorios/farmacología , Lectinas Tipo C/metabolismo , Macrófagos/efectos de los fármacos , Animales , Línea Celular , Supervivencia Celular/efectos de los fármacos , Citocinas/metabolismo , Lectinas Tipo C/genética , Macrófagos/metabolismo , Ratones , Proteínas Quinasas Activadas por Mitógenos/metabolismo , Óxido Nítrico/metabolismo , Fagocitosis/efectos de los fármacos , Zimosan
7.
BMC Complement Altern Med ; 15: 345, 2015 10 05.
Artículo en Inglés | MEDLINE | ID: mdl-26438076

RESUMEN

BACKGROUNDS: In the present study, we aimed to examine the anti-aging properties of human placental hydrolysate (HPE) and dieckol (DE) from Ecklonia cava against free radical scavenging, muscle hypertrophy-related follistatin mRNA expression, amelioration of cognition-related genes and proteins, inhibition of collagenase-regulating genes, and elastinase activity. METHODS: The anti-aging effects were examined in human fibroblast (CCD986sk), mouse myoblast (C2C12), and neuroblastoma (N2a) cell models, by employing various assays such as 2,2-diphenyl-1-picrylhydrazyl hydrate (DPPH) scavenging, hydroxyl radical-mediated oxidation, quantitative real-time polymerase chain reaction, enzyme activity, and immunocytochemistry observation. RESULTS: Our results show that HPE combined with DE (HPE:DE) strongly scavenged DPPH radicals and protected proteins against degradation by hydroxyl radical attack. HPE:DE effectively inhibited matrix metalloproteinase-1 expression, protein kinase C alpha expression, and elastinase activity. Furthermore, HPE:DE improved the expression of cognition-related genes (choline acetyltransferase and vesicular acetylcholine transporter). These events may proactively contribute to retard the aging processes and the abrupt physiological changes probably induced by mitochondrial dysfunction with aging. CONCLUSIONS: Based on these findings, we conclude that the combined treatment of HPE:DE may be useful for anti-aging therapy in which the accumulation of oxidative damage is the main driving force.


Asunto(s)
Envejecimiento/efectos de los fármacos , Benzofuranos/farmacología , Phaeophyceae/química , Placenta/química , Hidrolisados de Proteína/farmacología , Envejecimiento/genética , Envejecimiento/metabolismo , Animales , Línea Celular , Femenino , Depuradores de Radicales Libres/farmacología , Humanos , Metaloproteinasa 1 de la Matriz/genética , Metaloproteinasa 1 de la Matriz/metabolismo , Ratones , Estrés Oxidativo/efectos de los fármacos , Embarazo , Proteína Quinasa C-alfa/genética , Proteína Quinasa C-alfa/metabolismo , Especies Reactivas de Oxígeno/metabolismo
8.
Eur J Pharmacol ; 758: 1-10, 2015 07 05.
Artículo en Inglés | MEDLINE | ID: mdl-25848967

RESUMEN

We demonstrated previously that ginsenoside Rg3 enhances the expression of macrophage scavenger receptor class A (SRA) and amyloid ß peptide 1-42 (Aß42) uptake in BV2 cells. In this study, we investigated the biochemical and mechanistic roles of Rg3 in human microglia and animal models to identify the determinants that participate in restoring memory and learning in brains disrupted by the Aß42 peptide. SRA was expressed highly in Rg3-treated rats, and learning and memory functions were maintained at a normal level after the infusion of Aß42. SRA-transfected HMO6 human microglial cells (HMO6.hSRA) overexpressed SRA and took up a remarkable amount of Aß42. Rg3-treated HMO6 cells showed highly enhanced SRA expression and dramatically promoted Aß42 uptake. Moreover, high levels of clathrin and caveolin1 supported the roles of Rg3 in endocytic biogenesis by activating p38 and extracellular signal-regulated protein kinase signaling. Notably, both neprilysin (NEP) and insulin-degrading enzyme (IDE) were significantly expressed by Rg3, suggesting independent and compensatory hydrolytic activity for the Aß peptide. In conclusion, Rg3 successfully triggered Aß42 uptake via SRA and clathrin-/caveolae-mediated endocytic mechanisms and further contributed to accelerate the degradation of Aß peptide via the increase of intracellular NEP and IDE, which may be a promising Alzheimer׳s disease therapy.


Asunto(s)
Péptidos beta-Amiloides/metabolismo , Caveolina 1/metabolismo , Clatrina/metabolismo , Ginsenósidos/farmacología , Insulisina/metabolismo , Microglía/enzimología , Microglía/metabolismo , Fragmentos de Péptidos/metabolismo , Animales , Caveolina 1/síntesis química , Células Cultivadas , Clatrina/efectos de los fármacos , Humanos , Aprendizaje/efectos de los fármacos , Masculino , Memoria/efectos de los fármacos , Ratones , Microglía/efectos de los fármacos , Neprilisina/efectos de los fármacos , Neprilisina/metabolismo , Ratas , Receptores Depuradores de Clase A/metabolismo
9.
Cell Signal ; 27(6): 1246-52, 2015 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-25762490

RESUMEN

Small ubiquitin-like modifier (SUMO) 2 is a small protein that controls the activity and stability of other proteins by SUMOylation. In this study, T cell-specific SUMO2 overexpressing transgenic mice were generated to study the effect of SUMO2 on T lymphocytes. SUMO2 overexpression promoted differentiation of interleukin (IL)-17-producing CD8(+) T cells, and significantly suppressed the growth of EL4 tumor cells in vivo. Moreover, the tumor tissue from SUMO2-overexpressing mice had higher interferon (IFN)-γ and granzyme B mRNA levels. Although SUMO2 overexpression did not increase IFN-γ or granzyme B production in cytotoxic T lymphocytes, IL-12 treatment restored and increased IFN-γ secretion in IL-17-producing CD8(+) T cells. SUMO2 overexpression also increased gene expression of chemokines, CCL4, and CXCL10, which attract cytotoxic T lymphocytes to tumor tissues. Additionally, SUMO2-overexpressing T cells exhibited increased STAT3 phosphorylation, implying a SUMO2 target which up-regulates STAT3 activity governing IL-17A-producing CD8(+) T cell differentiation and antitumor immune responses.


Asunto(s)
Linfocitos T CD8-positivos/metabolismo , Interleucina-17/metabolismo , Proteínas Modificadoras Pequeñas Relacionadas con Ubiquitina/metabolismo , Animales , Linfocitos T CD8-positivos/citología , Linfocitos T CD8-positivos/efectos de los fármacos , Diferenciación Celular/efectos de los fármacos , Línea Celular Tumoral , Quimiocina CCL4/genética , Quimiocina CCL4/metabolismo , Quimiocina CXCL10/genética , Quimiocina CXCL10/metabolismo , Granzimas/genética , Granzimas/metabolismo , Proteínas I-kappa B/genética , Proteínas I-kappa B/metabolismo , Interferón gamma/genética , Interferón gamma/metabolismo , Interleucina-12/farmacología , Interleucina-17/genética , Interleucina-6/farmacología , Ratones , Ratones Endogámicos C57BL , Ratones Transgénicos , Inhibidor NF-kappaB alfa , Neoplasias/patología , Fosforilación/efectos de los fármacos , ARN Mensajero/metabolismo , Factor de Transcripción STAT3/metabolismo , Proteínas Modificadoras Pequeñas Relacionadas con Ubiquitina/genética , Células Th17/citología , Células Th17/efectos de los fármacos , Células Th17/metabolismo
10.
J Food Sci ; 79(7): C1323-30, 2014 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-24962619

RESUMEN

Ethanol metabolism produces harmful compounds that contribute to liver damage and cause an alcohol hangover. The intermediate metabolite acetaldehyde is responsible for alcohol hangover and CYP2E1-induced reactive oxygen species damage liver tissues. In this study, we examined whether ginsenoside-free molecules (GFMs) from steam-dried ginseng berries promote ethanol metabolism and scavenge free radicals by stimulating primary enzymes (alcohol dehydrogenase, aldehyde dehydrogenase, CYP2E1, and catalase) and antioxidant effects using in vitro and in vivo models. The results revealed that GFM effectively scavenged 2,2-diphenyl-1-picrylhydrazyl hydrate radicals and hydroxyl radicals. Notably, GFM significantly enhanced the expression of primary enzymes within 2 h in HepG2 cells. GFM clearly removed the consumed ethanol and significantly reduced the level of acetaldehyde as well as enhancement of primary gene expression in BALB/c mice. Moreover, GFM successfully protected HepG2 cells from ethanol attack. Of the major components identified in GFM, it was believed that linoleic acid was the most active ingredient. Based on these findings, we conclude that GFM holds promise for use as a new candidate for ethanol metabolism and as an antihangover agent.


Asunto(s)
Consumo de Bebidas Alcohólicas/efectos adversos , Etanol/metabolismo , Frutas/química , Ginsenósidos/química , Panax/química , Animales , Regulación Enzimológica de la Expresión Génica/efectos de los fármacos , Humanos , Hígado/efectos de los fármacos , Hígado/enzimología , Masculino , Ratones , Ratones Endogámicos BALB C , Distribución Aleatoria
11.
Biol Pharm Bull ; 37(5): 826-33, 2014.
Artículo en Inglés | MEDLINE | ID: mdl-24599032

RESUMEN

In Alzheimer's disease (AD), extensive neuronal loss and a deficiency of the neurotransmitter acetylcholine (ACh) are the major characteristics during pathogenesis in the brain. In the present study, we aimed to investigate whether representative ginsenosides from ginseng can regulate choline acetyltransferase (ChAT) and vesicular acetylcholine transporter (VAChT), which are required for cholinergic neurotransmission. Our results revealed that Re and Rd induced effectively the expression of ChAT/VAChT genes in Neuro-2a cells as well as ACh elevation. Microtubule-associated protein-2 (MAP-2), nerve growth factor receptor (p75), p21, and TrkA genes and proteins were also significantly expressed. Moreover, both activated extracelullar signal-regulated protein kinase (ERK) and Akt were inhibited by K252a, a selective Trk receptor inhibitor. These findings strongly indicate that Re and Rd play an important role in neuronal differentiation and the nerve growth factor (NGF)-TrkA signaling pathway. High performance liquid chromatography analysis showed that Re and Rd administered orally were transported successfully into brain tissue and increased the level of ChAT and VAChT mRNA. The present study demonstrates that Re and Rd are selective candidates for upregulation of the expression of cholinergic markers, which may counter the symptoms and progress of AD.


Asunto(s)
Acetilcolina/biosíntesis , Diferenciación Celular/efectos de los fármacos , Regulación de la Expresión Génica/efectos de los fármacos , Ginsenósidos/farmacología , Neuronas/citología , Neuronas/efectos de los fármacos , Animales , Biomarcadores/metabolismo , Línea Celular , Colina O-Acetiltransferasa/biosíntesis , Ginsenósidos/farmacocinética , Ratones , Proteínas Asociadas a Microtúbulos/biosíntesis , Neuronas/metabolismo , Receptor de Factor de Crecimiento Nervioso/biosíntesis , Receptor trkA/biosíntesis , Proteínas de Transporte Vesicular de Acetilcolina/biosíntesis , Proteínas de Unión al GTP rho/biosíntesis
12.
J Pharm Pharmacol ; 66(3): 466-76, 2014 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-24354475

RESUMEN

OBJECTIVES: In the present study, we aimed to examine whether fractions from an edible sea weed, Hizikia fusiformis, had immunomodulatory effects, particularly an anti-atopic effect, by attenuating the expression of T cell-dependent cytokines using in-vitro and in-vivo animal atopic dermatitis-like models. METHODS: The anti-atopic activities were examined in in vitro, and a 2,4-dinitrochlorobenzene (DNCB)-induced atopic dermatitis-like mouse model using quantitative real-time polymerase chain reaction, electrophoretic-mobility shift and histopathological analysis. KEY FINDINGS: Our results showed that the final fraction (F2') of H. fusiformis contained a higher amount of butanoic acid which was not found in the other fractions, and effectively inhibited T cell activation by inhibiting dephosphorylation of nuclear factor of activated T cells in electrophoretic-mobility shift assay. As a consequence, helper T cell-dependent cytokines, such as interleukin-2, -4 and interferon-γ, were significantly inhibited while activated with an anti-CD3 antibody. We also showed that skin challenged with DNCB successfully recovered when treated with 2.5 mg/kg, comparable to that by 0.25% prednicarbate. These results indicate that F2' may contribute to inhibit T cell activation by eliminating Th cell-dependent cytokines. CONCLUSIONS: Taken together, we concluded that F2' containing butanoic acid may be a new functional anti-atopic candidate, which probably acts through nuclear factor of activated T cell inactivation mechanisms.


Asunto(s)
Ácido Butírico/farmacología , Citocinas/metabolismo , Dermatitis Atópica/inmunología , Factores Inmunológicos/farmacología , Algas Marinas/química , Piel/efectos de los fármacos , Linfocitos T Colaboradores-Inductores/metabolismo , Animales , Anticuerpos/sangre , Ácido Butírico/análisis , Ácido Butírico/uso terapéutico , Complejo CD3/metabolismo , Dermatitis Atópica/inducido químicamente , Dermatitis Atópica/tratamiento farmacológico , Dermatitis Atópica/metabolismo , Dinitroclorobenceno , Modelos Animales de Enfermedad , Factores Inmunológicos/uso terapéutico , Activación de Linfocitos/efectos de los fármacos , Masculino , Ratones , Ratones Endogámicos BALB C , Factores de Transcripción NFATC/metabolismo , Fosforilación , Fitoterapia , Extractos Vegetales/farmacología , Extractos Vegetales/uso terapéutico
13.
Int J Nanomedicine ; 6: 2459-67, 2011.
Artículo en Inglés | MEDLINE | ID: mdl-22072881

RESUMEN

BACKGROUND: The aim of the present study was to enhance a topical delivery of hirsutenone (HST), a naturally occuring immunomodulator, employing Tat peptide-admixed elastic liposomes (EL/T). METHODS: HST-loaded EL, consisting of phosphatidylcholine and Tween 80 (85:15 w/w%), were prepared using thin film hydration method. By adding Tat peptide to EL (0.16 w/w%), EL/T were formulated. The in vitro skin permeation of HST was examined using a Franz diffusion cell mounted with depilated mouse skin. Lesions for atopic dermatitis (AD) were induced by a topical application of diphenylcyclopropenone to NC/Nga mice. Therapeutic improvements of AD were evaluated by clinical skin severity scores. Immunological analyses on inducible nitric oxide synthase and cyclooxygenase-2 levels in the skin and interleukin (IL)-4, IL-13, immunoglobulin E, and eosinophil levels in the blood were also performed. RESULTS: EL systems were superior to conventional cream, revealing greater flux values in a permeation study. The addition of Tat peptide further increased the skin permeation of HST. In an efficacy study with AD-induced NC/Nga mice, an HST-containing EL/T formulation brought a significant improvement in both skin severity score and immune-related responses for the levels of nitric oxide synthase, cyclooxygenase-2, IL-4, IL-13, immunoglobulin E, and eosinophils. CONCLUSION: A novel EL/T formulation was successfully developed for topical delivery of HST to treat AD.


Asunto(s)
Catecoles/administración & dosificación , Dermatitis Atópica/tratamiento farmacológico , Diarilheptanoides/administración & dosificación , Productos del Gen tat/química , Liposomas/farmacología , Animales , Catecoles/química , Catecoles/farmacología , Ciclooxigenasa 2/metabolismo , Dermatitis Atópica/sangre , Dermatitis Atópica/metabolismo , Diarilheptanoides/química , Diarilheptanoides/farmacología , Eosinófilos/efectos de los fármacos , Eosinófilos/metabolismo , Productos del Gen tat/administración & dosificación , Productos del Gen tat/farmacología , Inmunoglobulina E/sangre , Interleucina-13/sangre , Interleucina-4/sangre , Liposomas/administración & dosificación , Liposomas/química , Masculino , Ratones , Óxido Nítrico Sintasa/metabolismo , Fosfatidilcolinas , Polisorbatos , Absorción Cutánea/efectos de los fármacos
14.
J Pharm Pharmacol ; 63(10): 1327-35, 2011 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-21899549

RESUMEN

OBJECTIVES: In the present study, we aimed to examine the anti-atopic properties of bile from the cat fish, Silurus asotus, to determine its possible use as a pharmaceutical product. METHODS: The anti-atopic activities of cat fish bile were examined in a non-cell antioxidant, in-vitro assay (splenocytes and mast cells) and a 2,4-dinitrochlorobenzene (DNCB)-induced atopic dermatitis-like mouse model. RESULTS: The results of these experiments revealed that Silurus asotus bile (SAB) scavenges radicals and protects proteins from superoxide attacks, suggesting that SAB suppresses the T helper (Th) type 2-skewed immune response. Th1/Th2 mRNA cytokines (interleukin (IL)-2, interferon (IFN)-γ and IL-4) from mouse splenocytes were effectively inhibited, and the release of ß-hexosaminidase in RBL-2H3 mast cells was significantly suppressed by SAB. These results were supported by screening the Th1/Th2 cytokine mRNAs (IL-2, IFN-γ and IL-4) from lymph nodes in DNCB-treated mice. More dramatic results were observed in the histological changes at higher SAB concentrations (5%) compared to the therapeutic control, visualized using hematoxylin-eosin (H&E) staining. CONCLUSIONS: The results presented in this study suggest that SAB may provide functional advantages with regard to treating atopic dermatitis because of its antioxidant and immune-suppressive effects.


Asunto(s)
Antioxidantes/uso terapéutico , Bilis , Productos Biológicos/uso terapéutico , Bagres , Dermatitis Atópica/terapia , Piel/efectos de los fármacos , Linfocitos T/metabolismo , Animales , Antioxidantes/farmacología , Productos Biológicos/farmacología , Terapias Complementarias , Citocinas/antagonistas & inhibidores , Citocinas/genética , Dermatitis Atópica/inmunología , Dermatitis Atópica/metabolismo , Dinitroclorobenceno , Ganglios Linfáticos/efectos de los fármacos , Ganglios Linfáticos/metabolismo , Mastocitos/efectos de los fármacos , Mastocitos/metabolismo , Ratones , Ratones Endogámicos BALB C , Carbonilación Proteica/efectos de los fármacos , ARN Mensajero/metabolismo , Piel/patología , Bazo/citología , Bazo/efectos de los fármacos , Bazo/metabolismo , Superóxidos/metabolismo , Células TH1/efectos de los fármacos , Células TH1/metabolismo , Células Th2/efectos de los fármacos , Células Th2/metabolismo , beta-N-Acetilhexosaminidasas/antagonistas & inhibidores
15.
Phytother Res ; 25(10): 1564-9, 2011 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-21717518

RESUMEN

Recently, the isolation of several condensed tannins from the roots of Rosa multiflora Thunberg, a traditional herbal therapy in oriental medicine for rheumatoid arthritis and scabies, was described. Two of the major condensed tannins - procyanidin B-3 (ProB3) and ent-guibourtinidol-(4ß â†’ 6)-catechin (RM-1) - were then applied topically to atopic dermatitis-like skin lesions on NC/Nga mice in order to assess their immunomodulatory properties. Both ProB3 and RM-1 significantly reduced the serum levels of eosinophils, IgE and certain Th2 cytokines (IL-4, 5 and 13) (p < 0.05 or 0.01). Additionally, ProB3 and RM-1 significantly reduced both the mRNA and protein expression of COX-2 and iNOS in mouse skin tissues (p < 0.01). Such results strongly suggest that ProB3 and RM-1 may be useful in the treatment allergic skin conditions, most notably atopic dermatitis.


Asunto(s)
Biflavonoides/uso terapéutico , Catequina/uso terapéutico , Dermatitis Atópica/tratamiento farmacológico , Factores Inmunológicos/farmacología , Fitoterapia , Extractos Vegetales/uso terapéutico , Proantocianidinas/uso terapéutico , Rosa/química , Administración Tópica , Animales , Biflavonoides/farmacología , Catequina/análogos & derivados , Catequina/farmacología , Inhibidores de la Ciclooxigenasa/farmacología , Inhibidores de la Ciclooxigenasa/uso terapéutico , Citocinas/sangre , Dermatitis Atópica/inmunología , Dermatitis Atópica/metabolismo , Eosinófilos/metabolismo , Femenino , Inmunoglobulina E/sangre , Factores Inmunológicos/uso terapéutico , Ratones , Ratones Endogámicos , Óxido Nítrico Sintasa de Tipo II/metabolismo , Extractos Vegetales/farmacología , Raíces de Plantas , Proantocianidinas/farmacología , ARN Mensajero/metabolismo , Piel/efectos de los fármacos , Piel/inmunología , Piel/patología , Células Th2/metabolismo
16.
J Food Sci ; 76(2): H55-61, 2011 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-21535768

RESUMEN

UNLABELLED: Lactobacilli isolated from Kimchi, a Korean traditional food, were tested for their capacity to modulate the T helper (Th) 1/Th2 balance. Ovalbumin (OVA)-sensitized mouse splenocytes were cultured with 26 strains of lactobacilli; the highest IL-12 induction and lowest IL-4 production were then observed in 4 strains, including Lactobacillus plantarum CJLP55, CJLP56, CJLP133, and CJLP136. These strains produced a larger amount of IL-12, which enhances differentiation and activation of Th1 cells, in macrophage cell-lines more than positive control strains L. casei KCTC 3109(T) and L. rhamnosus GG, although they also induced production of IL-10, which is a suppressor of IL-12. Indeed, CJLP133-stimulated macrophages induced production of more Th1 cytokine IFN-γ and less Th2 cytokine IL-4 than KCTC 3109(T) and GG in co-cultivation with T cells. These findings suggest that lactobacilli from Kimchi may modulate the Th1/Th2 balance via macrophage activation in the hypersensitive reaction caused by Th2 cells. PRACTICAL APPLICATION: Allergic reactions including asthma and atopy are caused by predominance of Th2 response over Th1 response. Lactobacilli isolated from fermented foods such as yogurt, cheese, and Kimchi showed health-promoting activities. The present study indicated that several lactobacilli strains from Kimchi may reduce allergic reactions through macrophage-mediated induction of Th1 response.


Asunto(s)
Microbiología de Alimentos , Lactobacillus/aislamiento & purificación , Lactobacillus/metabolismo , Activación de Macrófagos , Balance Th1 - Th2/efectos de los fármacos , Animales , Línea Celular , Fermentación , Hipersensibilidad/inmunología , Interferón gamma/inmunología , Interleucina-10/inmunología , Interleucina-12/inmunología , Interleucina-4/inmunología , Macrófagos/efectos de los fármacos , Macrófagos/inmunología , Ratones , Ratones Endogámicos BALB C , Ovalbúmina , Células TH1/inmunología , Células Th2/inmunología
17.
Phytother Res ; 25(9): 1301-5, 2011 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-21312305

RESUMEN

The roots of Rhododendron mucronulatum Turzaninov have been used in Oriental traditional medicine for the treatment of dysuria, fever, increase of digestive activity and tonics in China and Korea. Activity guided isolation of the roots of Rhododendron mucronulatum Turzaninov has led to the isolation of three flavonoids, one flavan 3-ol and one proanthocyanidin. Chemical investigation of the 80% Me2 CO extract from the roots of Rhododendron mucronulatum led to the isolation and identification of five compounds: taxifolin (1), taxifolin 3-O-ß-D-glucopyranoside (2), quercetin 3-O-α-L-arabinofuranoside (3), (-)-epicatechin (4), procyanidin B-3 (5). To investigate the antioxidative and antiinflammatory effects of these compounds, their 1,1-diphenyl-2-picrylhydrazyl (DPPH) radical scavenging activities and the protein levels of inducible nitric oxide synthase (iNOS) and cyclooxygenase-2 (COX-2) in LPS-stimulated HaCaT cells were also quantified by western blotting and their end products, nitric oxide (NO) and prostaglandin E2 (PGE2 ), respectively. Compounds (1-5) showed potent DPPH radical scavenging compared with positive controls (L-ascorbic acid). Also, compounds 1 and 2 dose-dependently inhibited the expressions of inflammatory mediators, NO and PGE2 , suggesting they are promising candidates as antiinflammatory agents.


Asunto(s)
Inhibidores de la Ciclooxigenasa/farmacología , Óxido Nítrico Sintasa de Tipo II/antagonistas & inhibidores , Extractos Vegetales/farmacología , Rhododendron/química , Antiinflamatorios/farmacología , Antioxidantes/farmacología , Arabinosa/análogos & derivados , Arabinosa/farmacología , Biflavonoides/farmacología , Catequina/farmacología , Línea Celular , Ciclooxigenasa 2/metabolismo , Dinoprostona/metabolismo , Glucósidos/farmacología , Humanos , Óxido Nítrico/metabolismo , Raíces de Plantas/química , Proantocianidinas/farmacología , Quercetina/análogos & derivados , Quercetina/farmacología
18.
J Ethnopharmacol ; 136(3): 406-13, 2011 Jul 14.
Artículo en Inglés | MEDLINE | ID: mdl-21184819

RESUMEN

AIM OF THE STUDY: The bark of Alnus species has long been used in traditional oriental medicine in the treatment of many pathological conditions, including fever, hemorrhage, diarrhea, alcoholism, various skin diseases (e.g. chronic herpes, eczema and prurigo), and inflammation. In order to assess the immunomodulatory efficacy of a novel herbal medicine in treating atopic dermatitis, we measured serum levels of several allergic and inflammatory biomarkers in NC/Nga mice before and after treatment with this experimental agent. MATERIALS AND METHODS: Gene and protein expression analyses of iNOS and COX-2 were quantified by real time PCR and Western blot analysis and serum levels of IL-4, -5 and -13 were also measured by ELISA, all of which were reduced after treatment with the experimental agent. Additionally, serum concentrations of IgE and blood eosinophil counts were reduced in treated mice. RESULTS: The topical application of leaf and bark extract from Alnus japonica suppressed the development of AD-like skin lesions. The percent of blood eosinophils was decreased after treatment with leaf and bark extract from Alnus japonica. The serum IgE and Th2-related cytokine levels were decreased after treatment with leaf and bark extract from Alnus japonica compared with those treated with base cream (vehicle treated AD group). The IL-4, IL-5 and IL-13 were lower than those of vehicle treated AD group. CONCLUSIONS: We contend that leaf and bark extract from Alnus japonica may prove useful in the treatment of atopic dermatitis and other allergic skin diseases, although more in-depth clinical studies are necessary before clinical implementation.


Asunto(s)
Alnus , Dermatitis Atópica/tratamiento farmacológico , Fármacos Dermatológicos/uso terapéutico , Factores Inmunológicos/uso terapéutico , Fitoterapia , Extractos Vegetales/uso terapéutico , Piel/efectos de los fármacos , Animales , Citocinas/sangre , Dermatitis Atópica/inmunología , Dermatitis Atópica/patología , Fármacos Dermatológicos/farmacología , Modelos Animales de Enfermedad , Eosinófilos/metabolismo , Femenino , Inmunoglobulina E/sangre , Factores Inmunológicos/farmacología , Ratones , Ratones Endogámicos , Corteza de la Planta , Extractos Vegetales/farmacología , Hojas de la Planta , Piel/inmunología , Piel/patología , Células Th2/metabolismo
19.
Arch Pharm Res ; 33(11): 1825-33, 2010 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-21116786

RESUMEN

Programmed death-1 (PD-1) is a co-inhibitory receptor of the CD28/CTLA-4 family which is expressed on activated T cells and inhibits T cell activation after binding to PD-1 ligands. In animal models, PD-1 regulates autoimmune disease and induces tolerance in pancreas. In this study the effects of PD-1 on type 1 diabetes were examined using PD-1 transgenic mice (Tg). The incidence of autoimmune diabetes induced by multiple low dose of streptozotocin (STZ) was reduced in PD-1 Tg mice. Although the expression of CTLA-4, PD-1 and FoxP3, which are inhibitory molecules of activated T cells, is reduced only on STZ injected wild type (WT) mice, CD4, CD8 and regulatory T cell populations were not changed in all experimental groups. When splenocytes were re-stimulated in ex vivo, the production of IL-2 and IFN-γ and the T cell proliferation were increased in all STZ injected mice, but the increment rate was less in PD-1 Tg groups. Interestingly, macrophages were observed in splenocytes of STZ injected PD-1 Tg at somewhat lower level than macrophage in diabetic wild type mice. In this research, we found out that total numbers of T cell in the experimental groups are not changed, but T cell function is changed, and FoxP3 expression is decreased in pancreas and spleen of diabetes-induced groups. Macrophage frequency might also affects on type 1 diabetes. Although more experimental evidence needs to be provided, these results suggest that ligation of PD-1 and PD-L1/2 may have an effect on macrophages as well as does T cells.


Asunto(s)
Antígenos CD/metabolismo , Antígenos de Superficie/metabolismo , Proteínas Reguladoras de la Apoptosis/metabolismo , Diabetes Mellitus Experimental/prevención & control , Diabetes Mellitus Tipo 1/metabolismo , Diabetes Mellitus Tipo 1/prevención & control , Activación de Linfocitos , Linfocitos T/metabolismo , Animales , Antígenos CD/inmunología , Antígenos de Superficie/genética , Proteínas Reguladoras de la Apoptosis/genética , Antígeno B7-1/genética , Antígeno B7-1/metabolismo , Antígeno B7-H1 , Linfocitos T CD4-Positivos/inmunología , Linfocitos T CD4-Positivos/metabolismo , Linfocitos T CD8-positivos/inmunología , Linfocitos T CD8-positivos/metabolismo , Antígeno CTLA-4 , Diabetes Mellitus Experimental/inmunología , Diabetes Mellitus Experimental/metabolismo , Diabetes Mellitus Tipo 1/inmunología , Expresión Génica , Tolerancia Inmunológica , Interferón gamma/inmunología , Interferón gamma/metabolismo , Interleucina-2/inmunología , Interleucina-2/metabolismo , Macrófagos , Masculino , Glicoproteínas de Membrana/genética , Glicoproteínas de Membrana/metabolismo , Ratones , Ratones Endogámicos C57BL , Ratones Transgénicos , Péptidos/genética , Péptidos/metabolismo , Proteína 2 Ligando de Muerte Celular Programada 1 , Receptor de Muerte Celular Programada 1 , Linfocitos T/inmunología
20.
Biol Pharm Bull ; 33(11): 1854-60, 2010.
Artículo en Inglés | MEDLINE | ID: mdl-21048311

RESUMEN

In pancreatic islets, free radical formation produced upon exposure to proinflammatory cytokines mediates ß cell destruction, which ultimately leads to type 1 diabetes (T1D). In this study, we examined whether laccase, a family of the blue copper protein, can be successfully used to prevent ß cells from cytokine-mediated apoptosis. Non-obese diabetic (NOD) mice were used for these experiments. In parallel, the RINm5f ß cell line was employed as a model system for in vitro experiments. The results demonstrated that laccase effectively scavenged peroxinitrite, which can be formed by nitric oxide, and upregulated the expression of antioxidant enzymes, such as manganese superoxide dismutase (MnSOD) and catalase. Interestingly, laccase balanced pro- (Bax) and anti-apoptotic (Bcl-2) proteins in terms of both the mRNA and protein levels with a downregulation of cytochrome c protein in RINm5f cells. In addition, laccase maintained blood glucose concentrations at a normal level with a simultaneous increase in plasma insulin levels during the spontaneous induction of diabetes in NOD mice. In conclusion, the antioxidant potentials of laccase in scavenging free radicals and upregulation of antioxidant enzymes may exert its pro-survival effect by counteracting the increased intracellular oxidative stress, and, consequently, by inhibiting apoptosis induced by cytokine-mediated activation during the course of T1D.


Asunto(s)
Antioxidantes/farmacología , Apoptosis/efectos de los fármacos , Diabetes Mellitus Tipo 1/tratamiento farmacológico , Células Secretoras de Insulina/efectos de los fármacos , Lacasa/farmacología , Estrés Oxidativo/efectos de los fármacos , Polyporales/química , Animales , Antioxidantes/metabolismo , Antioxidantes/uso terapéutico , Glucemia/metabolismo , Citocromos c/metabolismo , Citocinas/metabolismo , Diabetes Mellitus Tipo 1/metabolismo , Femenino , Insulina/sangre , Células Secretoras de Insulina/fisiología , Lacasa/uso terapéutico , Ratones , Ratones Endogámicos NOD , Ácido Peroxinitroso/metabolismo , Fitoterapia , Ratas , Regulación hacia Arriba , Proteína X Asociada a bcl-2/genética , Proteína X Asociada a bcl-2/metabolismo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...